HIV patients could one day replace a daily pill for one that would last a week or more, should a new drug development deal struck this week prove successful.
Foster City-based Gilead Sciences Inc. (Nasdaq: GILD) is enlisting Massachusetts startup Lynd… […]
With pressure building for a COVID-19 drug — from the right, the left, patients, their families and an uneasy public in a weeks-long lockdown — Gilead Sciences Inc. said the drug developer’s emphasis is on speed but also safety and efficacy.
In an ope… […]
Gilead Sciences Inc. hopes to convert a parking lots on its sprawling Foster City campus into a 60,836-square-foot amenities building.
The company (NASDAQ: GILD) — known for its life-changing HIV/AIDS and hepatitis C drugs and one of the first cell th… […]